MORROWGENIX
associated with 2 other trademarks
Biological tissue, namely, blood, fat derived stem cells, fat derived collagen, collagen, cells, stem cells, umbilical cords and placentas for scienti...

Words that describe this trademark:

tissue blood  cells fat  stem cells  collagen collagen  biological tissue  blood fat  fat  derived 

Serial Number:

77617054

Mark:

MORROWGENIX

Status:

Abandoned-No Statement of Use filed

Status Date:

09-17-2012

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Biological tissue, namely, blood, fat derived stem cells, fat derived collagen, collagen, cells, stem cells, umbilical cords and placentas for scientific and clinical research use Cosmetic preparations for skin renewal; non-medicated skin care preparations; skin moisturizer; non-medicated skin care preparation for use in treating sun burn and chapping; sunscreen; skin preparations for UV protection in the nature of sun block; non-medicated skin care preparations for use in cosmetic peels; skin gel; cosmetics; medicated biologic compounds in the form skin soap Medicines for the treatment of aging, cosmetic appearance, wrinkles, dermal defects, wound healing, revascularization, skin laxity, skin redundancy, skin deformity, scar tissue, facial aging, facial rejuvenation, facial reconstruction, body rejuvenation, body reconstruction, body contouring, body augmentation, breast augmentation, buttock augmentation, mons augmentation, nasal augmentation, urinary incontinence, and erectile dysfunction; biological tissue, namely, blood, fat derived stem cells, fat derived collagen, collagen, cells, stem cells, umbilical cords and placentas for medical use; pharmaceuticals, namely, pharmaceutical skin lotions, antiinfective preparations, medicated anti-aging skin creams and lotions; medicated biologic compounds in the form of body lotion, skin lotion, skin creams, skin adjuvants, skin astringents, skin stimulants, skin regenerants, skin powder, skin oil, skin gel, skin moisturizer, skin colloid, and skin hydroge; medicated skin serums; biologic product, namely, human allograft, autograft, and xenograft tissue; biologic derivatives, namely, autologous cells, allogeneic cells, and cells for medical or clinical use; medicated serums for treatment of wounds, scars, burns, skin defects, cosmetic appearance, breast augmentation, limb regeneration, limb amputation, aging, wrinkles, dermal defects, wound healing, tissue revascularization, skin laxity, skin redundancy, skin deformity, scar tissue, facial aging, facial rejuvenation, facial reconstruction, body rejuvenation, body reconstruction, body contouring, body augmentation, buttock augmentation, mons augmentation, nasal augmentation, urinary incontinence, and erectile dysfunction; biological derivatives in the nature of cell membranes, cell proteins, extracellular matrix, hormones, neurotransmitters, hormone precursors, neurotransmitter precursors, signal transduction molecules, aromatic hydrocarbons, proteins, amino acids, carbohydrates, nucleic acids, DNA, RNA, phospholipids, lipids, electrolytes, and antibodies for medical use; conditioned media, namely, tissue culture media, tissue culture serums, and tissue culture additives for medical use; lyophilized agents, namely, freeze dried cells, cell extract, cell organelles, protein, lipids, and carbohydrates for medical use; medicated serums for use in tissue culture, scar tissue repair, body augmentation, fat removal, fat augmentation, wound healing, wound repair, tissue regeneration, and anti-aging; dermal filler, injectable dermal fillers, adjuvants for medical purposes; human allograft, autograft, and xenograft tissue; herbals, namely, herbal supplements medical devices, namely, a fat processing device for isolating adipose derived stem cells, precursor/progenitor cells, and/or fibroblasts from fat, and a cell isolation system primarily featuring a cell isolation device to produce fatty tissue enriched with adipose derived stem cells and/or isolate pure populations and subsets of adipose derived stem cells, fibroblasts or dermal, neuron, vascular, cartilage, muscle or bone progenitor/precursor cells; cell isolation devices for treatment of aging, cosmetic appearance, wrinkles, dermal defects, wound healing, revascularization, skin laxity, skin redundancy, scar tissue, facial rejuvenation, facial reconstruction, body rejuvenation, body reconstruction, urinary incontinence, erectile dysfunction, wounds, scars, burns, skin defects, breast augmentation, limb regeneration, limb amputation, tissue revascularization, skin deformity, facial aging, body contouring, body augmentation, buttock augmentation, mons augmentation, and nasal augmentation Cosmetic and plastic surgery

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

11-24-2009

Mark Drawing Status:

Standart Character Mark

Abandon Date:

09-17-2012

Business Name:

LAW OFFICES OF CLARK GROSS

Correspondent Name:

Recent Trademark filings by this company